ÂÜÀòÂÒÂ×

Ms. Ha is the Chief Financial Officer of Ventus Therapeutics. She brings to Ventus more than 15 years of diverse strategic and financial experience within the healthcare sector.

Prior to Ventus, Christine was a Managing Director in the healthcare investment banking group at Morgan Stanley, where she advised biopharmaceutical companies on a broad range of strategic and financing initiatives. Previously, Christine held positions at Credit Suisse, Greenhill & Co, Aisling Capital, and HSBC. In her 13 years in investment banking, she executed over $24 billion of transactions, including M&A, collaborations, and financings.

Christine received an MBA with honors from The Wharton School at The University of Pennsylvania and a BA with honors in Statistics and a BS in Mathematics from The University of Chicago.